Medtronic plc
MDT · NYSE
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Revenue | $34 | $32 | $31 | $32 |
| % Growth | 3.6% | 3.6% | -1.4% | – |
| Cost of Goods Sold | $12 | $11 | $11 | $10 |
| Gross Profit | $22 | $21 | $21 | $22 |
| % Margin | 65.3% | 65.3% | 65.7% | 68% |
| R&D Expenses | $3 | $3 | $3 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $11 | $11 | $10 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $3 | $2 | $3 |
| Operating Expenses | $16 | $16 | $15 | $16 |
| Operating Income | $6 | $5 | $5 | $6 |
| % Margin | 17.8% | 15.9% | 17.6% | 18.2% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $6 | $5 | $5 | $6 |
| Tax Expense | $1 | $1 | $2 | $0 |
| Net Income | $5 | $4 | $4 | $5 |
| % Margin | 13.9% | 11.4% | 12% | 15.9% |
| EPS | 3.63 | 2.77 | 2.83 | 3.75 |
| % Growth | 31% | -2.1% | -24.5% | – |
| EPS Diluted | 3.61 | 2.76 | 2.82 | 3.73 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $3 | $3 | $3 | $3 |
| EBITDA | $9 | $8 | $9 | $9 |
| % Margin | 27.5% | 25.3% | 27.9% | 27.7% |